Bharti Airtel, State Bank of India, Life Insurance Corporation of India, One 97 Communications Paytm, Adani Enterprises, ...

The lawsuit escalates an unusual, high-profile battle between two large pharmaceutical companies over ownership of a coveted ...

But last week, those words took on the force of law. On Tuesday, Texas Attorney General Ken Paxton filed a lawsuit against ...

Synthetic biology is ready for the next developmental milestone and America’s leadership depends on getting the financing right.

Gov. Glenn Youngkin announced a landmark partnership Friday with AstraZeneca, Lilly and Merck to create the nation’s largest ...

Over the past few decades, the Triangle’s life sciences sector has been a monolithic growth engine, but now it’s bifurcated.

Luca Maini, assistant professor of health care policy in the Blavatnik Institute at Harvard Medical School, studies competition and regulation in pharmaceutical markets.

AstraZeneca, Eli Lilly and Merck committed $120 million to develop an advanced pharmaceutical manufacturing training center in Central Virginia.

Alnylam Pharmaceuticals, Inc. is rated Hold due to high expectations, competitive threats, and revenue expansion. Learn more ...

The US Health Resources and Services Administration (HRSA) revealed the initial nine drugs to be included in the 340B rebate ...

We live in deeply polarizing times, but frustration with prescription drug costs is a rare issue of bipartisan agreement.

The Massachusetts Health Policy Commission (HPC) announced it will hold its Annual Health Care Cost Trends Hearing on November 12, 2025. This ...